Time running out’ in teen girl’s battle with TUBB4a leukodystrophy
Ali Waters-Candy has seen her daughter Aggie, 13, go from being a “healthy, happy and beautiful baby” to no longer being able to walk,...
top of page
- Dec 16, 2021
- 1 min
TUBB4A-associated leukodystrophy
Dr Dan Williams, CEO and Co-Founder of new biotech business SynaptixBio, discusses how the search is on to find the first treatment for...
156 views0 comments
- Dec 16, 2021
- 1 min
Business digest C&I Issue 11, 2021
SynaptixBio, an Oxford, UK-based research company, has been launched by a worldwide team of medical and pharmaceutical scientists to...
54 views0 comments
- Dec 16, 2021
- 1 min
New biotech firm launched to develop ‘revolutionary’ treatment for one of world’s rarest diseases
A new biotech business SynaptixBio has been launched to tackle one of the world’s rarest neurodegenerative diseases. SynaptixBio is...
86 views0 comments
- Dec 16, 2021
- 1 min
Oxford Biotech Firm Launches To Tackle Rare Disease – Insider Limited
A biotech business has launched in Oxford in a bid to tackle one of the world’s rarest diseases. SynaptixBio is working to develop a...
45 views0 comments
- Dec 16, 2021
- 1 min
Oxford biotech firm launches to tackle rare disease
A biotech business has launched in Oxford in a bid to tackle one of the world's rarest diseases. SynaptixBio is working to develop a...
28 views0 comments
- Aug 18, 2021
- 1 min
SynaptixBio launched with singular focus
A new biotech company has been launched with the goal of taking on one of the world’s rarest neurodegenerative… To continue reading...
21 views0 comments
- Aug 18, 2021
- 1 min
Danish biotech profile is helping to establish its fourth company abroad
Bent Jakobsen, who has previously co-founded three biotech companies abroad, is now helping to establish his fourth of its kind,...
38 views0 comments
- Aug 18, 2021
- 1 min
Synaptixbio sets off on quest to find therapy for rare CNS disease
U.K.’s Synaptixbio Ltd. has launched, aiming to tackle a rare and often fatal disease of the central nervous system (CNS), TUBB4a...
10 views0 comments
- Aug 18, 2021
- 1 min
Oxford biotech firm SynaptixBio launched to develop ‘revolutionary’ treatment
A new biotech business has been launched in Oxford to tackle one of the world’s rarest diseases. SynaptixBio is working to develop the...
23 views0 comments
- Aug 18, 2021
- 1 min
Biotech to develop treatment for neurodegenerative disease
A team of medical and pharmaceutical experts has founded SynaptixBio, an Oxford-based research company working to develop the world’s...
24 views0 comments
- Aug 18, 2021
- 1 min
This week in drug discovery (18-22 October)
News round-up by DDW’s Megan Thomas for 18-22 October DDW’s Megan Thomas has selected five stories which highlight the opportunities in...
8 views0 comments
- Aug 18, 2021
- 1 min
SynaptixBio Formed to Tackle One of the World’s Rarest Diseases
SynaptixBio CEO and Co-Founder Dan Williams/Courtesy SynaptixBio TUBB4a-related leukodystrophy is considered one of the rarest diseases...
33 views0 comments
bottom of page